More than a century after it was first synthesized, the therapeutic benefits of aspirin continue
to emerge. Aspirin has been shown to protect against the recurrence of colorectal adenomas
and carcinomas, and compelling evidence suggests its efficacy as an adjuvant agent in a
molecular subset. Specifically